The Effect of AKT Inhibition in α-synuclein-dependent Neurodegeneration

Overview

Journal Front Mol Neurosci

Specialty Molecular Biology

Date 2025 Feb 20

PMID 39974188

Authors

Bedri Ranxhi

Zoya R Bangash

Zachary M Chbihi

Sokol V Todi

Peter A LeWitt

Wei-Ling Tsou

Affiliations

Soon will be listed here.

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disorder affecting millions of individuals worldwide. A hallmark of PD pathology is the accumulation of α-synuclein (α-Syn), a small protein known to support neuronal development and function. However, in PD, α-Syn cumulatively misfolds into toxic aggregates that disrupt cellular processes and contribute to neuronal damage and neurodegeneration. Previous studies implicated the AKT signaling pathway in α-Syn toxicity in cellular models of PD, suggesting AKT as a potential therapeutic target. Here, we investigated the effect of AKT inhibition in a model of synucleinopathy. We observed that administration of the AKT inhibitor, A-443654 led to mild improvements in both survival and motor function in flies expressing human α-Syn. Genetic studies revealed that reduction of AKT levels decreased α-Syn protein levels, concomitant with improved physiological outcomes. The protective effects of AKT reduction appear to operate through the fly ortholog of NF-κB, Relish, suggesting a link between AKT and NF-κB in regulating α-Syn levels. These findings highlight the AKT cascade as a potential therapeutic target for synucleinopathies and provide insights into mechanisms that could be utilized to reduce α-Syn toxicity in PD and related disorders, such as multiple system atrophy.

References

Cuervo A, Stefanis L, Fredenburg R, Lansbury P, Sulzer D . Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science. 2004; 305(5688):1292-5. DOI: 10.1126/science.1101738. View

Heidari A, Yazdanpanah N, Rezaei N . The role of Toll-like receptors and neuroinflammation in Parkinson's disease. J Neuroinflammation. 2022; 19(1):135. PMC: 9172200. DOI: 10.1186/s12974-022-02496-w. View

Gallia G, Tyler B, Hann C, Siu I, Giranda V, Vescovi A . Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells. Mol Cancer Ther. 2009; 8(2):386-93. PMC: 4498795. DOI: 10.1158/1535-7163.MCT-08-0680. View

Patel N, Alam N, Libohova K, Dulay R, Todi S, Sujkowski A . Phenotypic defects from the expression of wild-type and pathogenic TATA-binding proteins in new Drosophila models of Spinocerebellar Ataxia Type 17. G3 (Bethesda). 2023; 13(10). PMC: 10542169. DOI: 10.1093/g3journal/jkad180. View

Manning B, Toker A . AKT/PKB Signaling: Navigating the Network. Cell. 2017; 169(3):381-405. PMC: 5546324. DOI: 10.1016/j.cell.2017.04.001. View

Brand A, Perrimon N . Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development. 1993; 118(2):401-15. DOI: 10.1242/dev.118.2.401. View

Xu D, Shan B, Lee B, Zhu K, Zhang T, Sun H . Phosphorylation and activation of ubiquitin-specific protease-14 by Akt regulates the ubiquitin-proteasome system. Elife. 2015; 4:e10510. PMC: 4733041. DOI: 10.7554/eLife.10510. View

Codolo G, Plotegher N, Pozzobon T, Brucale M, Tessari I, Bubacco L . Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies. PLoS One. 2013; 8(1):e55375. PMC: 3561263. DOI: 10.1371/journal.pone.0055375. View

Pulst S, Nechiporuk A, Nechiporuk T, Gispert S, Chen X, Lopes-Cendes I . Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet. 1996; 14(3):269-76. DOI: 10.1038/ng1196-269. View

10.

Johnson S, Prifti M, Sujkowski A, Libohova K, Blount J, Hong L . as a Model of Unconventional Translation in Spinocerebellar Ataxia Type 3. Cells. 2022; 11(7). PMC: 8997593. DOI: 10.3390/cells11071223. View

11.

Dong-Chen X, Yong C, Yang X, Chen-Yu S, Li-Hua P . Signaling pathways in Parkinson's disease: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2023; 8(1):73. PMC: 9944326. DOI: 10.1038/s41392-023-01353-3. View

12.

Kim C, Kwon S, Iba M, Spencer B, Rockenstein E, Mante M . Effects of innate immune receptor stimulation on extracellular α-synuclein uptake and degradation by brain resident cells. Exp Mol Med. 2021; 53(2):281-290. PMC: 8080790. DOI: 10.1038/s12276-021-00562-6. View

13.

Calabresi P, Mechelli A, Natale G, Volpicelli-Daley L, Di Lazzaro G, Ghiglieri V . Alpha-synuclein in Parkinson's disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis. 2023; 14(3):176. PMC: 9977911. DOI: 10.1038/s41419-023-05672-9. View

14.

Farid H, Sayed R, El-Shamarka M, Abdel-Salam O, Sayed N . PI3K/AKT signaling activation by roflumilast ameliorates rotenone-induced Parkinson's disease in rats. Inflammopharmacology. 2023; 32(2):1421-1437. PMC: 11006765. DOI: 10.1007/s10787-023-01305-x. View

15.

Palmieri M, Pal R, Nelvagal H, Lotfi P, Stinnett G, Seymour M . Corrigendum: mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases. Nat Commun. 2017; 8:15793. PMC: 5474731. DOI: 10.1038/ncomms15793. View

16.

Johnson J, Huang W, Roman G, Costa-Mattioli M . TORC2: a novel target for treating age-associated memory impairment. Sci Rep. 2015; 5:15193. PMC: 4614817. DOI: 10.1038/srep15193. View

17.

Morgan M, Liu Z . Crosstalk of reactive oxygen species and NF-κB signaling. Cell Res. 2010; 21(1):103-15. PMC: 3193400. DOI: 10.1038/cr.2010.178. View

18.

Vazquez-Velez G, Gonzales K, Revelli J, Adamski C, Naini F, Bajic A . Doublecortin-like Kinase 1 Regulates α-Synuclein Levels and Toxicity. J Neurosci. 2019; 40(2):459-477. PMC: 6948939. DOI: 10.1523/JNEUROSCI.1076-19.2019. View

19.

Prifti M, Libohova K, Harris A, Tsou W, Todi S . Ubiquitin-binding site 1 of pathogenic ataxin-3 regulates its toxicity in models of Spinocerebellar Ataxia Type 3. Front Neurosci. 2023; 16:1112688. PMC: 9887036. DOI: 10.3389/fnins.2022.1112688. View

20.

Sarkar S, Dammer E, Malovic E, Olsen A, Raza S, Gao T . Molecular Signatures of Neuroinflammation Induced by αSynuclein Aggregates in Microglial Cells. Front Immunol. 2020; 11:33. PMC: 7006296. DOI: 10.3389/fimmu.2020.00033. View